New Zealand Doctor | New Zealand Doctor
Assisting seniors who live alone to preserve their independence. By 2028 the number of New Zealanders aged 65 years or older is expected to reach one million, a nearly 20% increase from 2022. 1 With an ageing population, the adoption of public policies to encourage. Read more.
Thousands of Kiwis Set to Access Newly Funded ... - New Zealand …
Mar 1, 2023 — [1] Strezova A et al. Long-term protection against herpes zoster (HZ) by the adjuvanted recombinant zoster vaccine (RZV): interim efficacy, immune and safety results at approximately 10 years after initial vaccination. Open Forum Infectious Diseases. 2022 [2] Immunisation Advisory Centre. Shingrix. Accessible here. …
+All News | New Zealand Doctor
Low HPV vax rates missed opportunity to address health inequities. With over $150 million spent on HPV-related cancers in three years, improving HPV vaccination rates would cut costs and save lives, write Amelia Jenkinson, Cathy Stephenson and Swee Tan. Read more. Amelia Jenkinson, Cathy Stephenson and Swee Tan. Monday 21 October 2024, 04:35 PM.
The newspaper - New Zealand Doctor
New Zealand Doctor Rata Aotearoa is a medical news publication providing up-to-date news in print and online, aimed primarily at GPs and primary care. It was launched in 1989 and has been published by The Health Media since July 2015. Our brief is broad – if it affects GPs and primary care, its business, staff, patients or ethos, we’re ...
Older Kiwis urged to get COVID-19 boosters - New Zealand Doctor
Dec 13, 2023 — 2 minutes to Read. As Kiwis prepare for Christmas, public health officials are recommending that people who are more likely to experience severe COVID-19, such as Māori and Pacific people aged 50 and over, as well as everyone aged 65 and older, get a booster vaccine before the holidays. Dr Nicholas Jones Director of Public Health says New ...
Adverse events following immunisation with COVID-19 …
Nov 5, 2021 — Adverse events following immunisation with COVID-19 vaccines: Safety Report #33 – 16 October 2021. Medsafe advises people NOT to make any decisions about vaccination based on information contained in this report.
Osteoporosis - New Zealand Doctor
Mar 27, 2024 — The ANZFFR Annual Report 2024 shows 95 per cent of anti-osteoporosis treatment used is either oral or intravenous bisphosphonate. Oral agents available in New Zealand are alendronate (Fosamax and Fosamax Plus) and risedronate, and the intravenous agent for use in osteoporosis is zoledronate.
Are Covid-19 treatments working? – Expert Q&A
Mar 16, 2022 — Those with mild disease need no specific COVID treatments, but low doses of blood-thinning treatment may be commenced because COVID-19 can cause problems with blood clots. When there is evidence of lung inflammation (pneumonitis), more intense blood-thinning therapy may be used. "Once there is a sustained need for additional oxygen, immune ...
Pfizer’s oral COVID-19 treatment arrives in New Zealand
Thursday 31 March 2022, 11:46 AM. The first shipment of Pfizer’s new oral antiviral treatment for COVID-19, Paxlovid, has arrived in New Zealand and will be available for those who need it from next week. “While vaccinations and booster shots are the best defence against COVID-19, having more treatments is important for those who become ...
COVID-19 | New Zealand Doctor
Oct 17, 2024 — An epidemiologist, commenting on a study of COVID-19 and the immune system differentiated by age group, is urging New Zealand authorities to expand the offer of COVID vaccination to most young children. Read more. By Martin Johnston. Wednesday 9 October 2024, 02:00 AM. 2 minutes to Read.